Physician

Frank S. Ashburn, MD

According to 2025 Medicare claims, Frank Ashburn, MD (NPI: 1538426051) practices ophthalmology in the Washington, DC-MD market, with the plurality of this provider's patient population coming from The District, DC. This provider's primary affiliated billing organization is EYE ASSOCIATES OF WASHINGTON, DC PC (NPI: 1750350583; TIN: 520957293) and primary practice location at 20016-4360.

Ashburn's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,417 traditional Medicare patients, billed 3,853 HCPCS/CPT codes, and received $412,366 in Medicare payments. The top billing code was 66984 (Removal of cataract with insertion of prosthetic lens). Part D data shows 1,394 prescription claims across 415 beneficiaries totaling $232,345 in drug costs, led by Restasis (Cyclosporine). Open Payments data shows 20 records totaling $1,064. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $8,668 to $412,366. Similarly, Part D prescription costs have risen steadily, from $17,007 to $232,345. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$215K$429K2017 Medicare payment: $8,668 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $48,623 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $264,483 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $233,224 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $322,049 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $355,258 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $429,182 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $412,366 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
201793172$8,668
2018345563$48,623
20199361,821$264,483
20207401,647$233,224
20211,0192,508$322,049
20221,2173,023$355,258
20231,3713,587$429,182
20241,4173,853$412,366

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$116K$232K2015 Drug cost: $17,007 (USD; Tot_Drug_Cst)2016 Drug cost: $25,083 (USD; Tot_Drug_Cst)2017 Drug cost: $88,707 (USD; Tot_Drug_Cst)2018 Drug cost: $198,249 (USD; Tot_Drug_Cst)2019 Drug cost: $59,052 (USD; Tot_Drug_Cst)2020 Drug cost: $67,606 (USD; Tot_Drug_Cst)2021 Drug cost: $90,388 (USD; Tot_Drug_Cst)2022 Drug cost: $113,851 (USD; Tot_Drug_Cst)2023 Drug cost: $136,347 (USD; Tot_Drug_Cst)2024 Drug cost: $232,345 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201576231$17,007
201685303$25,083
2017324893$88,707
20184222,044$198,249
2019181361$59,052
2020163434$67,606
2021198496$90,388
2022231654$113,851
2023293876$136,347
20244151,394$232,345

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
66984Removal of cataract with insertion of prosthetic lens177294$476
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more184184$112
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more818826$100
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more575815$75
92250Photography of the retina1,0201,051$30

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RestasisCyclosporine393,030$60,076
XiidraLifitegrast161,200$27,241
LumiganBimatoprost462,598$24,993
VyzultaLatanoprostene Bunod241,572$17,044
Restasis MultidoseCyclosporine11432$9,740

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.20$1,064ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Frank S. Ashburn, MD?

Tedicare shows public-source Medicare data for Frank S. Ashburn, MD (NPI 1538426051), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Frank S. Ashburn, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Frank S. Ashburn, MD?

Frank S. Ashburn, MD is linked to EYE ASSOCIATES OF WASHINGTON, DC PC (billing NPI 1750350583) in the available physician profile data.

Does Frank S. Ashburn, MD have Open Payments data?

Frank S. Ashburn, MD has 20 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.